Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.45 PLN | -0.43% | -4.18% | -16.73% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 49.01 | 102.9 | 63.95 | 236.5 | 213.2 | 159.3 |
Enterprise Value (EV) 1 | 78.02 | 143.6 | 123.3 | 268.5 | 272.7 | 229.3 |
P/E ratio | 8.53 x | 20.4 x | 9.06 x | 4.15 x | 13.7 x | 12.2 x |
Yield | 6% | 7.86% | 4.6% | - | - | 1.54% |
Capitalization / Revenue | 0.24 x | 0.38 x | 0.22 x | 0.53 x | 0.54 x | 0.42 x |
EV / Revenue | 0.38 x | 0.53 x | 0.42 x | 0.6 x | 0.69 x | 0.61 x |
EV / EBITDA | 5.16 x | 8.79 x | 6.15 x | 3.07 x | 7.59 x | 6.66 x |
EV / FCF | 94 x | -18.8 x | 77 x | 5.81 x | -23.5 x | -20.8 x |
FCF Yield | 1.06% | -5.31% | 1.3% | 17.2% | -4.25% | -4.82% |
Price to Book | 0.9 x | 1.84 x | 1.16 x | 2.8 x | 2.74 x | 1.75 x |
Nbr of stocks (in thousands) | 12,252 | 12,252 | 12,252 | 12,252 | 12,252 | 12,252 |
Reference price 2 | 4.000 | 8.400 | 5.220 | 19.30 | 17.40 | 13.00 |
Announcement Date | 3/26/18 | 3/25/19 | 3/30/20 | 4/23/21 | 4/24/23 | 4/24/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 206.9 | 269.3 | 296.8 | 445.9 | 395.3 | 377.2 |
EBITDA 1 | 15.12 | 16.34 | 20.04 | 87.37 | 35.94 | 34.45 |
EBIT 1 | 7.5 | 8.167 | 10.68 | 75.61 | 23.39 | 20.88 |
Operating Margin | 3.63% | 3.03% | 3.6% | 16.96% | 5.92% | 5.54% |
Earnings before Tax (EBT) 1 | 7.127 | 6.028 | 8.26 | 71.55 | 21 | 14.15 |
Net income 1 | 5.746 | 5.05 | 7.063 | 56.93 | 15.58 | 13.08 |
Net margin | 2.78% | 1.88% | 2.38% | 12.77% | 3.94% | 3.47% |
EPS 2 | 0.4690 | 0.4122 | 0.5765 | 4.647 | 1.272 | 1.068 |
Free Cash Flow 1 | 0.8302 | -7.623 | 1.602 | 46.24 | -11.59 | -11.04 |
FCF margin | 0.4% | -2.83% | 0.54% | 10.37% | -2.93% | -2.93% |
FCF Conversion (EBITDA) | 5.49% | - | 7.99% | 52.92% | - | - |
FCF Conversion (Net income) | 14.45% | - | 22.67% | 81.22% | - | - |
Dividend per Share 2 | 0.2400 | 0.6600 | 0.2400 | - | - | 0.2000 |
Announcement Date | 3/26/18 | 3/25/19 | 3/30/20 | 4/23/21 | 4/24/23 | 4/24/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 29 | 40.7 | 59.4 | 32 | 59.6 | 70 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.919 x | 2.492 x | 2.963 x | 0.3664 x | 1.657 x | 2.032 x |
Free Cash Flow 1 | 0.83 | -7.62 | 1.6 | 46.2 | -11.6 | -11 |
ROE (net income / shareholders' equity) | 10.9% | 9.19% | 12.7% | 81.6% | 19.2% | 15.5% |
ROA (Net income/ Total Assets) | 3.67% | 3.59% | 4.12% | 24.7% | 6.68% | 5.67% |
Assets 1 | 156.6 | 140.7 | 171.3 | 230.6 | 233.3 | 230.8 |
Book Value Per Share 2 | 4.440 | 4.570 | 4.490 | 6.900 | 6.360 | 7.420 |
Cash Flow per Share 2 | 0.0600 | 0.0500 | 0.0600 | 0.5200 | 0.1700 | 0.0600 |
Capex | - | 30.7 | 17.1 | 16.2 | 21 | 16.1 |
Capex / Sales | - | 11.42% | 5.77% | 3.63% | 5.32% | 4.28% |
Announcement Date | 3/26/18 | 3/25/19 | 3/30/20 | 4/23/21 | 4/24/23 | 4/24/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-16.73% | 34.64M | |
+5.19% | 267B | |
+0.68% | 45.49B | |
+21.81% | 23.61B | |
+36.43% | 17.34B | |
-8.85% | 16.72B | |
+14.01% | 12.04B | |
+2.50% | 11.01B | |
+10.37% | 10.31B | |
-9.41% | 7.88B |
- Stock Market
- Equities
- KVT Stock
- Financials Krynica Vitamin S.A.